Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 26;6(1):41-45.
doi: 10.1159/000530251. eCollection 2023 Jan-Dec.

Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain

Affiliations

Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain

Sebastian Jugl et al. Med Cannabis Cannabinoids. .
No abstract available

Keywords: Cannabidiol; Cannabis; Chronic pain; Dosing; Marijuana; Tetrahydrocannabinol.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Similar articles

Cited by

References

    1. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–97. 10.1016/S0140-6736(21)00393-7. - DOI - PubMed
    1. Chou R, Wagner J, Ahmed AY, Morasco BJ, Kansagara D, Selph S, et al. . Living systematic review on cannabis and other plant-based treatments for chronic pain: 2022 update. Comparative effectiveness review No. 250. (Prepared by Pacific Northwest Evidence-based Practice Center under Contract No. 75Q80120D00006.) AHRQ Publication No. 22-EHC042. Rockville, MD: Agency for Healthcare Research and Quality; September 2022. 10.23970/AHRQEPCCER250UPDATE2022. Posted final reports are located on the Effective Health Care Program search page. - DOI
    1. Jugl S, Okpeku A, Costales B, Morris EJ, Alipour-Haris G, Hincapie-Castillo JM, et al. . A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019. Med Cannabis Cannabinoids. 2021. Feb 25;4(1):21–42. - PMC - PubMed
    1. Jean-Jacques J, Cook R, Winterstein AG, Goodin A, Brown JD, Jugl S, et al. . Priorities for medical marijuana research from the perspective of physicians, dispensary owners/staff, and patients: a survey study. Med Cannabis Cannabinoids. 2021;4(2):107–13. 10.1159/000518105. - DOI - PMC - PubMed
    1. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018 Mar;49:12–9. 10.1016/j.ejim.2018.01.004. - DOI - PubMed